Company / Free Cash Flow
Haemonetics Free Cash Flow History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$143.6M
FY2026
5-year range
$81.7M / $143.6M
FY2022-FY2026
Trend
-
vs FY2025
Sector context
#75 of 151
Health Care
What the data says
At $144M, Haemonetics's free cash flow ranks #75 of 151 in the Health Care sector. Free Cash Flow has fluctuated over the past 9 years, ranging from $40M in FY2018 to $146M in FY2017.
Based on SEC 10-K filings.
$144M in FY2026 with a 5-year CAGR of +13.6%.
Remained stable around $144M over the past 3 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- +0.0%
- 5-Year CAGR
- +13.6%
- 10-Year CAGR
- -
Sector benchmark
#75 of 151 in Health CareTop 50% of 151This company $143.6M Sector average $779.8M
▼
-81.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +13.6%, indicating consistent growth.
- Ranks #75 out of 151 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2017.
- Lowest free cash flow in the period was in FY2018.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $143.6M | - |
| FY2025 | - | - |
| FY2024 | $142.4M | -0.8% |
| FY2023 | $143.6M | +75.7% |
| FY2022 | $81.7M | +7.9% |
| FY2021 | $75.8M | +5.6% |
| FY2020 | $71.8M | -34.4% |
| FY2019 | $109.5M | +171.5% |
| FY2018 | $40.3M | -72.3% |
| FY2017 | $145.6M | +74.1% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026